Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of TFPI mRNA | decreases expression | 18648102
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of TFPI mRNA | affects expression | 16483693
|
D000661 |
Amphetamine |
Amphetamine results in decreased expression of TFPI protein | decreases expression | 20118172
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of TFPI mRNA | increases expression | 18687144
|
D001554 |
Benzene |
Benzene results in decreased expression of TFPI mRNA | decreases expression | 15929907
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TFPI mRNA | decreases expression | 20018196
|
D002995 |
Clofibric Acid |
Clofibric Acid affects the expression of TFPI mRNA | affects expression | 17602206
|
D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TFPI mRNA | affects cotreatment|affects expression | 17602206
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of TFPI mRNA | decreases expression | 20106945
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TFPI mRNA | affects cotreatment|affects expression | 17602206
|
D004317 |
Doxorubicin |
TFPI protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TFPI mRNA | affects cotreatment|increases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in decreased expression of and results in decreased secretion of TFPI protein | decreases expression|decreases secretion | 17029634
|
D004958 |
Estradiol |
Estradiol results in increased expression of TFPI mRNA | increases expression | 19619570
|
D004966 |
Estrogens, Conjugated (USP) |
Estrogens, Conjugated (USP) affects the expression of TFPI mRNA | affects expression | 15964915
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of and results in decreased secretion of TFPI protein | decreases expression|decreases secretion | 17029634
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased activity of TFPI protein | decreases activity | 15857755
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of TFPI mRNA | decreases expression | 17557909
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of TFPI protein | decreases expression | 15857755
|
D004997 |
Ethinyl Estradiol |
fulvestrant inhibits the reaction [Ethinyl Estradiol results in decreased activity of TFPI protein] | decreases activity|decreases reaction | 15857755
|
D004997 |
Ethinyl Estradiol |
norethindrone acetate promotes the reaction [Ethinyl Estradiol results in decreased activity of TFPI protein] | decreases activity|increases reaction | 15857755
|
D005047 |
Etoposide |
TFPI protein affects the susceptibility to Etoposide | affects response to substance | 16217747
|
D005472 |
Fluorouracil |
TFPI protein affects the susceptibility to Fluorouracil | affects response to substance | 16217747
|
C065180 |
fluvastatin |
fluvastatin results in increased expression of TFPI protein | increases expression | 16142594
|
C070081 |
fulvestrant |
[fulvestrant co-treated with Raloxifene] results in increased secretion of TFPI protein | affects cotreatment|increases secretion | 17029634
|
C070081 |
fulvestrant |
fulvestrant inhibits the reaction [Raloxifene results in decreased expression of and results in decreased secretion of TFPI protein] | decreases expression|decreases reaction|decreases secretion | 17029634
|
C070081 |
fulvestrant |
fulvestrant results in decreased secretion of TFPI protein | decreases secretion | 17029634
|
C070081 |
fulvestrant |
fulvestrant inhibits the reaction [Ethinyl Estradiol results in decreased activity of TFPI protein] | decreases activity|decreases reaction | 15857755
|
C070081 |
fulvestrant |
fulvestrant inhibits the reaction [norethindrone acetate results in decreased activity of TFPI protein] | decreases activity|decreases reaction | 15857755
|
D019833 |
Genistein |
Genistein results in decreased expression of TFPI mRNA | decreases expression | 18847459
|
D019833 |
Genistein |
Genistein results in increased expression of TFPI mRNA | increases expression | 17341692
|
C051890 |
irinotecan |
irinotecan analog results in decreased expression of TFPI mRNA | decreases expression | 18927307
|
D016685 |
Mitomycin |
TFPI protein affects the susceptibility to Mitomycin | affects response to substance | 16217747
|
C024262 |
norethindrone acetate |
fulvestrant inhibits the reaction [norethindrone acetate results in decreased activity of TFPI protein] | decreases activity|decreases reaction | 15857755
|
C024262 |
norethindrone acetate |
norethindrone acetate promotes the reaction [Ethinyl Estradiol results in decreased activity of TFPI protein] | decreases activity|increases reaction | 15857755
|
C024262 |
norethindrone acetate |
norethindrone acetate results in decreased activity of TFPI protein | decreases activity | 15857755
|
C024262 |
norethindrone acetate |
norethindrone acetate results in decreased expression of TFPI protein | decreases expression | 15857755
|
D020849 |
Raloxifene |
[fulvestrant co-treated with Raloxifene] results in increased secretion of TFPI protein | affects cotreatment|increases secretion | 17029634
|
D020849 |
Raloxifene |
fulvestrant inhibits the reaction [Raloxifene results in decreased expression of and results in decreased secretion of TFPI protein] | decreases expression|decreases reaction|decreases secretion | 17029634
|
D020849 |
Raloxifene |
Raloxifene results in decreased expression of and results in decreased secretion of TFPI protein | decreases expression|decreases secretion | 17029634
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of TFPI mRNA | increases expression | 19072884
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased expression of and results in decreased secretion of TFPI protein | decreases expression|decreases secretion | 17029634
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TFPI mRNA | affects cotreatment|increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of TFPI mRNA | decreases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TFPI mRNA | increases expression | 19619570
|
D014028 |
Tobacco Smoke Pollution |
Tobacco Smoke Pollution results in increased expression of TFPI mRNA | increases expression | 18087596
|
D019772 |
Topotecan |
TFPI protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.32 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.62 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.33 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.71 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
12.91 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
12.91 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
12.91 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
12.91 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
12.91 | 11473722 |
MESH:D002282 |
Adenocarcinoma, Bronchiolo-Alveolar |
|
Tobacco Smoke Pollution |
5.30 | 15814487 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
6.23 | 3712494 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.23 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
9.29 | 19061943 17162532 17620307 18056438 19052882 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.29 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.47 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.67 | 16712894 17306315 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
10.73 | 21441931 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
10.73 | 17308373 17451421 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.49 | 15800139 |
MESH:D019969 |
Amphetamine-Related Disorders |
|
Amphetamine |
5.83 | 15010207 16916582 18475255 16459022 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.02 | 15504547 17963324 16511603 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.02 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
4.20 | 11369114 14761424 17661222 |
MESH:D000855 |
Anorexia |
|
Amphetamine |
4.81 | 12183048 16084549 16101753 12005258 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.24 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.53 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tobacco Smoke Pollution |
3.13 | 19898480 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.63 | 11514358 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.79 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.84 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.56 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.62 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
5.00 | 16183116 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
11.39 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
11.39 | 14601052 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.25 | 16580743 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.61 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
8.05 | 11921183 17162533 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
8.05 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
8.05 | 15136595 15692762 18382427 16935488 17426702 17983394 18695136 15634643 16264153 15993339 15567936 19526202 15939500 15994142 17369602 18628466 16595493 18234424 16322301 16115903 16096432 15668708 16826403 11325840 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
8.05 | 12948864 16675129 17289903 19861407 17018787 14630087 18497071 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
8.05 | 16322251 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
8.05 | 15136595 18608205 19217205 16557594 16110121 16595493 18357371 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
8.05 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
8.05 | 16541309 16873071 17200150 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
8.05 | 16912660 17595753 17893378 16837676 17261762 17440819 17242785 15572757 17952589 15775269 17049068 15758505 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
8.05 | 19103187 20859285 20005174 18815881 18997820 17261762 17242785 19084267 19059307 17893378 19289846 15565566 16818667 19189210 16273361 21152245 20065188 19189212 20135344 19115204 11161223 18629630 18984771 19142967 19066611 19288272 19244106 20544844 18821012 16202921 19155303 15668708 18425577 19011961 18351453 19487384 21138602 18855134 17440819 19410462 19200415 17049068 20390343 16873071 19221464 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
8.05 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.23 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
11.58 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
11.58 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
7.59 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.59 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.28 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
16.26 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
16.26 | 17138121 3581430 19052882 16830150 17173139 18665156 17761372 10737359 18393292 16328049 18506893 18978308 20007298 19919837 16288022 20514400 19701751 18788625 19171122 16807293 18210153 18494052 3084413 20524982 16779866 11831363 16569478 19383236 20727157 19519916 19539802 18971187 21159647 19335982 17978847 19394651 19822196 20084675 17055752 20432363 10672840 19107877 16502159 20512989 17428255 16698587 16681979 20214788 17162532 20935162 19208518 18056438 16540662 20101231 18691550 18785209 16878318 19418558 16935385 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
16.26 | 16234567 18059187 16023760 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
16.26 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
16.26 | 17088986 16332177 18930000 16799960 17971768 17045692 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
16.26 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
16.26 | 17306315 16507464 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
16.26 | 16924424 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Tobacco Smoke Pollution |
3.35 | 11212258 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
10.16 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
10.16 | 1485588 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
10.16 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
10.30 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
10.30 | 18986760 17066447 16757204 16280240 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
10.30 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tobacco Smoke Pollution |
10.30 | 11212258 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
8.84 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
8.84 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.24 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.38 | 17007740 17329180 17131338 17974986 16364871 18627295 16952015 16109756 16612575 16651473 16242529 15476868 16455267 17924179 15811867 15505089 16278810 16269455 17382496 15792986 17351982 17519947 17928571 17308081 16731534 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.87 | 17334414 16243910 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
6.98 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
6.98 | 15775269 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
24.34 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
24.34 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
24.34 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
24.34 | 21159647 7505956 2727394 17174075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
24.34 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
24.34 | 19524636 20056578 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.69 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.69 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
12.42 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
12.42 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
12.42 | 17110522 11677210 17333356 16919318 15861022 17681005 16105132 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.01 | 12621046 8697196 15668235 16354765 15340226 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.39 | 15800139 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
5.65 | 16340194 18772588 16510598 17169374 17172411 17725105 17016597 15001691 17018589 17287894 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
5.65 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
5.65 | 17725105 17287894 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.42 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
3.42 | 16303861 16282729 17401013 18448328 15148649 16524972 18509181 17094418 18383874 17695437 15289873 18949393 14970324 18288408 17454858 17594712 16331619 20501625 18802399 16391804 17255274 17016601 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
3.42 | 17159606 18509181 18259882 16303861 17454858 16391804 15273666 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.87 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
fluvastatin |
4.67 | 16142594 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
2.60 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.60 | 20055451 15322242 10048152 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.56 | 16733453 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.14 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.97 | 17474826 |
MESH:D003872 |
Dermatitis |
|
Benzene |
4.54 | 15902427 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.59 | 2524372 11298694 14531868 12868966 11906362 8970840 8156756 18759878 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.28 | 2952479 3621924 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.76 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
6.76 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.76 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
13.91 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
13.91 | 15920148 17451421 17308373 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
13.91 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
8.40 | 11289319 7440962 18289764 8291058 18692083 9328219 9022650 1440618 16192314 9653073 6679447 18648102 6482804 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
8.40 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
8.40 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.40 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.56 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.56 | 11462148 |
MESH:D004487 |
Edema |
|
Raloxifene |
6.18 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.18 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.67 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
14.08 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
14.08 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
14.08 | 19031437 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.36 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
16.59 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
16.59 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
16.59 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
16.59 | 19155303 20544844 16202921 17893378 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.82 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.93 | 18037988 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.89 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.88 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.88 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
6.88 | 15173087 16481741 17638652 16337965 16785472 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.84 | 11564622 |
MESH:D005221 |
Fatigue |
|
Amphetamine |
5.37 | 19890266 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
22.47 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
22.47 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
22.47 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
22.47 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
22.47 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.10 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.23 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.79 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.30 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
10.68 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
10.68 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
7.74 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.74 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.45 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.99 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
6.85 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
6.85 | 16598420 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.78 | 16145905 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.82 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.36 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
7.41 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
7.41 | 15162350 18337622 15102660 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.21 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
7.32 | 14766674 17875725 16144979 16495754 16244371 16879835 18674790 16244372 16707910 18006777 17888722 12587719 16330681 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
7.32 | 11110106 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.20 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.70 | 15692506 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.44 | 16183116 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.19 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.13 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.30 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.67 | 16120746 15340226 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.80 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
4.33 | 10809021 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
11.27 | 18501091 17606976 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
11.27 | 18180244 15147373 16200630 16135485 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
11.27 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.52 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.81 | 8697196 18606429 16959395 15340226 16354765 |
MESH:D006948 |
Hyperkinesis |
|
Amphetamine |
5.20 | 1977408 14960337 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.71 | 15034207 |
MESH:D006973 |
Hypertension |
|
Benzene |
11.67 | 17940673 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
11.67 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
11.67 | 15787275 17577099 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
11.67 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.58 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.25 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
10.43 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
10.43 | 11514358 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
10.43 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
11.01 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
11.01 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
11.01 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Tobacco Smoke Pollution |
11.01 | 18590791 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.82 | 16627594 16393666 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.79 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.21 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
13.38 | 10903974 8314463 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
13.38 | 15369732 16775033 15699352 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
13.38 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
13.38 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
3.95 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
21.37 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
21.37 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
21.37 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
21.37 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
21.37 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.28 | 16973256 |
MESH:D007938 |
Leukemia |
|
Benzene |
6.26 | 17119257 18335105 15935818 14694614 |
MESH:D007938 |
Leukemia |
|
Genistein |
6.26 | 18980019 17468513 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.93 | 16085563 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
4.11 | 17506065 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
2.66 | 19478238 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.99 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.70 | 19638242 20032147 18522880 18665156 18407596 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.06 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
6.42 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.42 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
6.42 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
6.42 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.42 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.05 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
20.56 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
20.56 | 15885732 19427195 20101389 19499222 19996281 19638242 21071580 16942905 21167192 19812893 2422723 19690152 20434301 20137499 18977376 20452335 18648771 19426721 19642983 12771043 15175105 18754104 20118626 21278145 19850985 19073162 19254457 19833225 19294768 18644402 20405173 12112319 20492335 2862719 20583210 9163691 19256749 19551842 10737359 20501860 18978307 19255062 19090486 21047994 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
20.56 | 15113037 18383874 16603448 17045692 |
MESH:D008113 |
Liver Neoplasms |
|
Mitomycin |
20.56 | 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
20.56 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
20.56 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
20.56 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
17.16 | 3712494 1399818 6587162 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
17.16 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
17.16 | 19004024 18544905 3124819 18093689 9362446 18775883 18308698 19126423 21159647 18079962 17174075 17942915 19539802 18164116 18282651 18253720 19009564 16842330 17854601 16267830 2563599 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
17.16 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
17.16 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.02 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
4.58 | 14698565 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
3.80 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
12.48 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
12.48 | 6695378 21163286 20512841 20970405 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
12.48 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
12.48 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
12.48 | 16712894 17306315 19931552 15276417 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
12.48 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
12.48 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Tobacco Smoke Pollution |
12.48 | 16288123 3440675 11091918 12111688 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.56 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Benzene |
11.81 | 17119257 17584886 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
11.81 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
11.81 | 12854902 12556972 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.61 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.34 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
9.31 | 12562636 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
9.31 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
17.29 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
17.29 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
17.29 | 11408345 11807958 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
17.29 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
17.29 | 19196722 11731420 19196723 14580682 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.87 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.87 | 19453300 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
4.89 | 16827129 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
4.89 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
4.89 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.95 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
6.13 | 16166281 16966607 18303189 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.13 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.56 | 16801185 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.29 | 15792986 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.32 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
8.38 | 16757204 18986760 |
MESH:D009062 |
Mouth Neoplasms |
|
Tobacco Smoke Pollution |
8.38 | 15006635 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
11.65 | 17415656 |
MESH:D052016 |
Mucositis |
|
irinotecan |
11.65 | 17159606 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
11.48 | 17119195 |
MESH:D009101 |
Multiple Myeloma |
|
fluvastatin |
11.48 | 16996129 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
11.48 | 16497877 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.66 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
5.66 | 17141266 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.84 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.94 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
7.94 | 17141266 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.32 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
16.96 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
16.96 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
16.96 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
16.96 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
16.96 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.44 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
4.81 | 18600527 16928823 18239605 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
4.81 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.44 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.77 | 19196722 19200415 19189210 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.50 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.54 | 16636307 16899518 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.21 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
8.66 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
8.66 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
15.10 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
15.10 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
15.10 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
11.36 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
11.36 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
11.36 | 12854658 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
10.91 | 15555623 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
10.91 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
Topotecan |
10.91 | 15176712 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Amphetamine |
8.22 | 15183010 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
8.22 | 20387270 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.50 | 8761367 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.89 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.29 | 16436463 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
8.50 | 4026338 6482804 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
8.50 | 15935809 15727169 16737584 17479406 15913788 15612468 17119257 17178637 15576619 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.79 | 3988306 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
6.87 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
6.87 | 17882678 15775268 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
9.44 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
9.44 | 15579764 17823083 17893378 15758505 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.93 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
10.72 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.72 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
10.72 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
10.72 | 15276417 17306315 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
11.74 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
11.74 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
11.74 | 19003803 16500647 16929163 15113037 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Mitomycin |
11.74 | 15113037 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.47 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.26 | 7296757 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.02 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.24 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.93 | 17983394 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.67 | 10923243 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.93 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.34 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.31 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
8.31 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.96 | 11118676 11399792 11222880 11896295 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.68 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.41 | 16888761 15897917 16868541 18437689 16729912 15749863 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.41 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
2.41 | 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.41 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.41 | 16925846 15256057 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.41 | 16536755 16220300 15731164 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.41 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.41 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.09 | 16919318 15861022 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.15 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
2.94 | 17365031 17975199 15814490 17322281 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.32 | 15770314 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.82 | 18722050 18286688 16160472 15538739 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.00 | 17922066 |
MESH:D012135 |
Respiratory Sounds |
|
Tobacco Smoke Pollution |
4.40 | 18410779 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.21 | 3692021 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.79 | 15675481 18313854 17710206 17203757 15625365 16767912 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
9.82 | 16326096 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
9.82 | 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.56 | 17846226 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
12.74 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
12.74 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
12.74 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tobacco Smoke Pollution |
12.74 | 18590791 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.34 | 17203757 15625365 16767912 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.79 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.79 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.81 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.62 | 12854658 |
MESH:D019956 |
Stereotypic Movement Disorder |
|
Amphetamine |
6.19 | 1977408 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
4.59 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
4.59 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
4.59 | 17498489 17522103 17172411 16424979 18567086 19084572 19015929 15786421 18396642 16951190 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
4.59 | 15723263 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.64 | 16837676 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.41 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.96 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
4.73 | 10850423 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.67 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.00 | 3712494 7505956 1399818 6582329 6587162 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
11.00 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
11.00 | 16010429 17909728 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
12.94 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
12.94 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.79 | 16280240 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
18.72 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
18.72 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
18.72 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
18.72 | 16712894 17306315 11723127 16452187 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
18.72 | 16712894 17572228 8653321 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tobacco Smoke Pollution |
18.72 | 12846360 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
8.83 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
8.83 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
8.84 | 12562636 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
8.84 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.75 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.20 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.36 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.98 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.33 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.00 | 16364871 17678736 17638931 17334414 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.32 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.02 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.21 | 17120751 |